Welcome Stockaholics!

We are a new and fast growing financial forum! Sign up for free and let's talk stocks!

  1. Do you want to help develop this community? We are looking for contributions from investors and traders like you! What stocks do you follow? What is hot right now? Sign up and get in on the ground floor of the newest, fastest growing financial forum!
    Dismiss Notice
  2. You will notice a live chat widget on the right. Click in to join us and lets hear about how you nailed that last UWTI trade!
    Dismiss Notice

ARKG - Genomic Revolution ETF

Discussion in 'Investing' started by emmett kelly, Oct 10, 2020.

  1. emmett kelly

    emmett kelly Well-Known Member

    Dec 21, 2017
    Likes Received:
    The investment seeks long-term growth of capital. The fund is an actively-managed exchange-traded fund ("ETF") that will invest under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including healthcare, information technology, materials, energy and consumer discretionary, that are relevant to the fund's investment theme of the genomics revolution ("Genomics Revolution Companies"). It is non-diversified.



    The Brontide likes this.
  2. emmett kelly

    emmett kelly Well-Known Member

    Dec 21, 2017
    Likes Received:
    biotech is hot with all the covid hysteria. get it now. said hysteria goes bye bye when election is over.


    8:20 am ET October 13, 2020 (Benzinga) Print

    Here's a roundup of top developments in the biotech space over the last 24 hours:

    Scaling The Peaks

    (Biotech Stocks Hitting 52-week Highs Oct. 12)

    • 10X Genomics Inc (NASDAQ: TXG)
    • Acceleron Pharma Inc (NASDAQ: XLRN)
    • Adaptive Biotechnologies Corp (NASDAQ: ADPT)
    • Applied Molecular Transport Inc. (NASDAQ: AMTI)
    • Arena Pharmaceuticals, Inc. (NASDAQ: ARNA)
    • argenx SE – ADR (NASDAQ: ARGX)
    • Beigene Ltd (NASDAQ: BGNE)
    • Bio-Rad Laboratories, Inc. Class A Common Stock (NYSE: BIO)
    • Blueprint Medicines Corp (NASDAQ: BPMC)
    • Calliditas Therapeutics Adr Rep 2 Ord Shs (NASDAQ: CALT)
    • Cardiff Oncology Inc (NASDAQ: CRDF)
    • CareDx Inc (NASDAQ: CDNA)
    • Castle Biosciences Inc (NASDAQ: CSTL)
    • Denali Therapeutics Inc (NASDAQ: DNLI)
    • Fate Therapeutics Inc (NASDAQ: FATE)
    • Immunovant Inc (NASDAQ: IMVT)
    • Insmed Incorporated (NASDAQ: INSM)
    • Intellia Therapeutics Inc (NASDAQ: NTLA)
    • Jazz Pharmaceuticals PLC (NASDAQ: JAZZ)
    • Kronos Bio Inc (NASDAQ: KRON) (went public Friday)
    • Kura Oncology Inc (NASDAQ: KURA)
    • Kymera Therapeutics Inc (NASDAQ: KYMR)
    • Lantern Pharma Inc. (NASDAQ: LTRN)
    • Natera Inc (NASDAQ: NTRA)
    • Nevro Corp (NYSE: NVRO)
    • Novocure Ltd (NASDAQ: NVCR)
    • Orphazyme A S ADR (NASDAQ: ORPH)
    • Repligen Corporation (NASDAQ: RGEN)
    • Rocket Pharmaceuticals Inc (NASDAQ: RCKT)
    • Pacific Biosciences of California Inc (NASDAQ: PACB)
    • SpringWorks Therapeutics Inc (NASDAQ: SWTX)
    • Stoke Therapeutics Inc (NASDAQ: STOK)
    • Surface Oncology Inc (NASDAQ: SURF) -moved on reports of the company exploring a potential sale and Bristol-Myers Squibb Co (NYSE: BMY) expressing interest
    • Tcr2 Therapeutics Inc (NASDAQ: TCRR)
    • TG Therapeutics Inc common stock (NASDAQ: TGTX)
    • Turning Point Therapeutics Inc (NASDAQ: TPTX)
    • Twist Bioscience Corp (NASDAQ: TWST)
    • Veracyte Inc (NASDAQ: VCYT)
    • Vericel Corp (NASDAQ: VCEL)
    • Zai Lab Ltd – ADR (NASDAQ: ZLAB)
    • West Pharmaceutical Services Inc. (NYSE: WST)
    • Zoetis Inc (NYSE: ZTS)
    anotherdevilsadvocate likes this.
  3. anotherdevilsadvocate

    anotherdevilsadvocate Well-Known Member

    Apr 3, 2016
    Likes Received:
    This has been a strong ETF this year.
    Weekly chart relative to SPY

    I make a list of the ETF holdings in tradingview, /ARKG,
    to try to find the ones that are strong within the ETF.

Share This Page